| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.006 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-07 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.2 |